Release Date: 09/04/13 09:16 Summary: Positive results for Viralytics CAVATAK phase 1 IV Study Price Sensitive: Yes Download Document 78.04KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status